-
1. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.
Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, Kato K, Kato H, Kawakubo H, Kawachi H, Kuribayashi S, Kono K, Kojima T, Takeuchi H, Tsushima T, Toh Y, Nemoto K, Booka E, Makino T, Matsuda S, Matsubara H, Mano M, Minashi K, Miyazaki T, Muto M, Yamaji T, Yamatsuji T, Yoshida M. Esophagus. 2023 Jul;20(3):343-372.
-
2. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2.
Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, Kato K, Kato H, Kawakubo H, Kawachi H, Kuribayashi S, Kono K, Kojima T, Takeuchi H, Tsushima T, Toh Y, Nemoto K, Booka E, Makino T, Matsuda S, Matsubara H, Mano M, Minashi K, Miyazaki T, Muto M, Yamaji T, Yamatsuji T, Yoshida M. Esophagus. 2023 Jul;20(3):373-389.
-
3. Interaction between Medical Treatment and Minimally Invasive Surgical Treatment for the Malignancies of the Digestive Tract.
Kato H, Ono H, Hamamoto Y, Ishikawa H. Digestion. 2018;97(1):13-19.
-
4. Treatments for esophageal cancer: a review.
Kato H, Nakajima M. Gen Thorac Cardiovasc Surg. 2013 Jun;61(6):330-5.
-
5. The efficacy of FDG-PET for the management of esophageal cancer: review article.
Kato H, Nakajima M. Ann Thorac Cardiovasc Surg. 2012;18(5):412-9.
-
6. The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer.
Kato H, Nakajima M, Sohda M, Tanaka N, Inose T, Miyazaki T, Fukuchi M, Oriuchi N, Endo K, Kuwano H.Cancer. 2009 Jul 15;115(14):3196-203.
-
7. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer.
Kato H, Kimura H, Nakajima M, Sakai M, Sano A, Tanaka N, Inose T, Faried A, Saito K, Ieta K, Sohda M, Fukai Y, Miyazaki T, Masuda N, Fukuchi M, Ojima H, Tsukada K, Oriuchi N, Endo K, Kuwano H. Oncol Rep. 2008 Oct;20(4):857-62.
-
8. Videofluoroscopic evaluation in oropharyngeal swallowing after radical esophagectomy with lymphadenectomy for esophageal cancer.
Kato H, Miyazaki T, Sakai M, Sano A, Tanaka N, Kimura H, Inose T, Faried A, Saito K, Sohda M, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H. Anticancer Res. 2007 Nov-Dec;27(6C):4249-54.
-
9. Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography.
Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, Kimura H, Faried A, Saito K, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Oriuchi N, Endo K, Nonaka T, Shioya M, Ishikawa H, Sakurai H, Nakano T, Kuwano H.Anticancer Res. 2007 Jul-Aug;27(4C):2627-33.
-
10. Endoscopic clips prevent self-expandable metallic stent migration.
Kato H, Fukuchi M, Miyazaki T, Manda R, Faried A, Takita J, Nakajima M, Sohda M, Fukai Y, Masuda N, Tsukada K, Kuwano H.Hepatogastroenterology. 2007 Jul-Aug;54(77):1388-90.
-
11. Surgical treatment for esophageal cancer. Current issues.
Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, Kimura H, Faried A, Saito K, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Kuwano H.Dig Surg. 2007;24(2):88-95.
-
12. A novel technique to facilitate laparoscopic repair of large paraesophageal hernias.
Kato H, Miyazaki T, Kimura H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H.Am J Surg. 2006 Apr;191(4):545-8.
-
13. Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.
Kato H, Fukuchi M, Miyazaki T, Nakajima M, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Kuwano H.Anticancer Res. 2005 Sep-Oct;25(5):3461-7.
-
14. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.Anticancer Res. 2005 Nov-Dec;25(6C):4439-44.
-
15. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H.J Surg Oncol. 2005 May 1;90(2):89-94.
-
16. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.Cancer. 2005 Jan 1;103(1):148-56.
-
17. Serum p53 antibodies in drainage blood from the azygos vein in patients with esophageal carcinoma.
Kato H, Nakajima M, Fukuchi M, Miyazaki T, Manda R, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Tsukada K, Kuwano H.Anticancer Res. 2005 Sep-Oct;25(5):3231-5.
-
18. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H, Fukuchi M, Manda R, Faried A, Takita J, Nakajima M, Miyazaki T, Sohda M, Fukai Y, Masuda N, Tsukada K, Kuwano H.Anticancer Res. 2004 Nov-Dec;24(6):4091-6.
-
19. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Kuwano H.Br J Surg. 2004 Aug;91(8):1004-9.
-
20. Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.
Kato H, Fukuchi M, Manda R, Nakajima M, Miyazaki T, Sohda M, Masuda N, Fukai Y, Tsukada K, Kuwano H.Anticancer Res. 2003 Jul-Aug;23(4):3493-8.
-
21. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.Anticancer Res. 2003 Jul-Aug;23(4):3263-72.
-
22. Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma.
Kato H, Miyazaki T, Nakajima M, Takita J, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Asao T, Kuwano H, Oriuchi N, Endo K.Cancer. 2003 Sep 1;98(5):932-9.
-
23. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
Kato H, Miyazaki T, Fukai Y, Nakajima M, Sohda M, Takita J, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Asao T, Kuwano H.J Surg Oncol. 2003 Sep;84(1):24-30.
-
24. Prediction of hematogenous recurrence in patients with esophageal carcinoma.
Kato H, Miyazaki T, Nakajima M, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.Jpn J Thorac Cardiovasc Surg. 2003 Nov;51(11):599-608.
-
25. Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer.
Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Masuda N, Fukuchi M, Manda R, Tsukada K, Oriuchi N, Endo K.Am J Surg. 2002 Sep;184(3):279-83.
-
26. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K.Cancer. 2002 Feb 15;94(4):921-8.
-
27. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H.Anticancer Res. 2002 Sep-Oct;22(5):2635-9.
-
28. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.
-
29. Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma.
Kato H, Miyazaki T, Yoshikawa M, Nakajima M, Fukai Y, Masuda N, Ojima H, Tsukada K, Nishida Y, Kuwano H.Anticancer Res. 2001 Sep-Oct;21(5):3323-9.
-
30. Congenital bronchoesophageal fistula with Crohn's disease in an adult: report of a case.
Kato H, Yoshikawa M, Saito T, Fukuchi M, Kato R, Kuwano H.Surg Today. 2001;31(5):446-9.
-
31. Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers.
Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Tajima K, Masuda N, Tsukada K, Fukuda T, Nakajima T, Kuwano H.Cancer Lett. 2001 Jun 10;167(1):65-72.
-
32. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T.Anticancer Res. 2000 Jan-Feb;20(1A):345-9.
-
33. Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression.
Kato H, Miyazaki T, Yoshikawa M, Nakajima M, Fukai Y, Tajima K, Masuda N, Tsutsumi S, Tsukada K, Nakajima T, Kuwano H.Cancer Lett. 2000 May 29;153(1-2):121-7.
